1 / 62

Pediatric Hospital Medicine Top 10 Articles

Pediatric Hospital Medicine Top 10 Articles. Elena Aragona Jamie Librizzi. Objectives. Summarize important evidence-based literature relating to pediatric hospital medicine Appraise key PHM articles as they relate to clinical practice. Apparent Life-Threatening Events. Patient 1:

taber
Télécharger la présentation

Pediatric Hospital Medicine Top 10 Articles

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Pediatric Hospital MedicineTop 10 Articles Elena Aragona Jamie Librizzi

  2. Objectives • Summarize important evidence-based literature relating to pediatric hospital medicine • Appraise key PHM articles as they relate to clinical practice

  3. Apparent Life-Threatening Events • Patient 1: 5 month old female p/w ALTE • Difficulty catching breath • Face turned red • Lasted ~10 seconds • 15min after feed • Patient 2: Ex 34 wk 2mo M p/w ALTE • Hx ALTE 2 wks ago • Went limp for ~30 seconds • Not associated with feed

  4. P: In infants presenting with ALTEI/C: are there any factorsO: that increase risk of subsequent event?

  5. Management of Apparent Life-Threatening Events in Infants: A Systematic Review • Objective: lit review to determine • Hx and PE features that suggest inc risk of future adverse event and/or serious dx • What testing is indicated • Methods: • Pertinent articles identified and critically appraised • 1970-2011 • ALTE in children <24mo • Results: • 37 studies identified • 14 investigated history/PE features • 31 evaluated diagnostic testing • All studies observational; none well suited to define w/u or determine prognosis…

  6. Management of Apparent Life-Threatening Events in Infants: A Systematic Review • Results: • Features associated with future adverse event and/or serious underlying diagnosis • Prematurity • Multiple ALTE • Suspected child abuse • Little evidence to support routine testing of all patients without these risk factors

  7. Meningitis • ED calls re: 6yo M with fever & headache found to have CSF pleocytosis, would like to admit on IV abx for bacterial meningitis r/o

  8. P: In children presenting pleocytosisI/C: Is there a clinical score to identify children with high risk forO: Bacterial Meningitis

  9. JAMA

  10. Clinical Prediction Rule for Identifying Children with CSF Pleocytosis at Very Low Risk of Bacterial Meningitis • Objective: • To validate clinical prediction rule (Bacterial Meningitis Score) • Methods: • Review records of children with meningitis evaluated in ED of 20 academic medical centers over 4 years • Inclusion: 29d – 19yo with ICD9 diagnosis of meningitis • Exclusion: • Critical illness, purpura, VP shunt, recent neurosurgery, immunosuppression, other bacterial infection requiring inptabx, active lyme disease, pts with abx within 72h of LP • Bacterial meningitis: + CSF culture OR CSF pleocytosis with + BCxOR CSF pleocytosis with + CSF latex agllutination test for bacteria • N = 2903 (met inclusion criteria, data available)

  11. Clinical Prediction Rule for Identifying Children with CSF Pleocytosis at Very Low Risk of Bacterial Meningitis • Results: • 1714 low risk patients • 2 had bacterial meningitis (infants 1-2mo w E Coli meningitis and UTI; neg UA at presentation) • NPV: 99.9%, (95% CI 99.6%-100%) • 1189 not low risk • 119 (10%) had bacterial meningitis • >/= 1 risk factor • Sensitivity 98.3% (95% CI 94.2%-99.8%) • Specificity 61.5% (95% CI 59.7%-63.3% • Use caution when applying to infants <2mo • In patients >2mo, >/=1 risk factor had sensitivity 100% • Pts <2mo, >/=1 risk factor had sensitivity 92.3%

  12. Blood Cultures • 20mo M with L thigh cellulitis • Failed outpt therapy; plan to admit on clindamycin • Blood culture?

  13. P: In patients with asthma, bronchiolitis, pneumonia, SSTII: does obtaining blood cultureC: versus no blood cultureO: affect outcomes?

  14. Do We Need This Blood Culture? Kavita Parikh, Aisha Barber Davis, Padmaja Pavuluri Hospital Pediatrics 2014; 4; 78 DOI: 10.1542/hpeds.2013-0053

  15. Do We Need This Blood Culture? • Objective: • To assess BCx rates & results for 4 leading pediatric diagnoses in low-risk patients • Methods: • Retrospective cohort • Review records over 1 y at CNMC • Inclusion: 6mo – 18yo with bronchiolitis, asthma, SSTI, CAP • Exclusion: complex pts • N = 5159 (1629 inpt, 3530 outpt/ED)

  16. Do We Need This Blood Culture? • Results: • BCx in 343 pts: • 21% of inpts, 3% of ED/outpts • 4% in asthma • 15% in bronchiolitis • 36% in pna • 46% in SSTI • BCx results • Asthma – all neg • Bronchiolitis – all neg • SSTI – 98% neg or contaminant • 2 MRSA, 1 GAS • CAP – 99% neg or contaminant • 1 strep pneumo, 1 moraxella • BCx • Longer LOS in asthma, bronchiolitis • If + (n=5), no change in management • Some got rptBCx though • ~$100,000 microbiology costs at our institution

  17. SBI Rule Out in Infant • 3 wk M with fever • Well appearing, labs reassuring • Admitted on IV antibiotics

  18. P: Neonates <1 mo admitted w/fever for IV antibiotics I: Discharge at 36hC: Discharge at 48 hourO: No missed/untreated SBI

  19. Time to Detection of Bacterial Cultures in Infants Aged 0-90 days Rianna C. Evans and Brian Fine Hospital Pediatrics 2013;3;97 DOI: 10.152/hpeds.2012-0025

  20. Time to Detection of Bacterial Cultures in Infants Aged 0-90 days • Objective: determine if bacterial cultures in infants <90d would grow pathogenic bacteria in <36h • Methods • Retrospective Chart Review over 3.5y @ single institution • Infants 0 to 90 d evaluated in ED or inpt for SBI • Excluded: indwelling catheters, ‘sick’, rpt cx • Data Collection • Manual chart review of all blood, urine, CSF cultures • True + vs. contaminant - Determined based on tx

  21. Time to Detection of Bacterial Cultures in Infants Aged 0-90 days • CNMC: • BCx: checked q10min, alarm if +  gram stain, team called • First subsequent read at 16-18 hours, then q24h • CSF cultures • Goal gram stain within 1 hour • First time to check culture: 16-18 hours, then q24h • Urine cultures • First read at 16-18 hours, then daily • Can call at night and ask someone to check if still neg

  22. Time to Detection of Bacterial Cultures in Infants Aged 0-90 days • Results • 2092 blood cultures; 101/115 + blood cultures included in analysis • 97% true pathogen (n=38) Bcx grew in 36h • 2283 urine cultures; 192/232 + urine cultures included in analysis • 95% true pathogen (n=111) Ucxgrew in 36h • 1159 csf cultures; all 14+ included in analysis • 86% true pathogen (n=7) CSFcx grew in 36h

  23. UTI Length of Treatment in Infant • 3mo F with fever found to have UTI • Admitted on Ceftriaxone

  24. P: Infants admitted with UTII: Transition to oral antibiotics after 3dC: versus longer IV therapyO: Treatment failure

  25. Length of Intravenous Antibiotic Therapy and Treatment Failure in Infants with Urinary Tract Infections Patrick W. Brady, Patrick J. Conway and Anthony Goudie Pediatrics 2010; 126; 196 DOI: 10.1542/peds.2009-2948

  26. Length of IV Abx Therapy in Infants with UTI • Objective: • To assess short (<=3d) v long (>=4d) IV abx therapy and treatment failure in infants <6mo admitted with UTI • Treatment failure = readmit within 30d • Methods: • Retrospective cohort, infants <6mo admitted to 24 children's hospitals over 5y with UTI or pyelo (PHIS) • Excluded kids w complex conditions

  27. Length of IV Abx Therapy in Infants with UTI • Results: 12,333 kids met inclusion criteria • Male gender, neonatal status, black, Hispanic, non-private insurance, known bacteremia, GU abnormality – inc likelihood of receiving IV abx

  28. Length of IV Abx Therapy in Infants with UTI • Results • Treatment failure overall: 1.9% • 1.6% in short-course, 2.2% in long-course • Ie maybe sicker pts got long iv abxs and more likely to fail • Outcome by pt characteristic and length of IV abx • ie gender, age by 1month intervals, race, bacteremia, GU abnormality) • Only GU abnormality and severity of illness associated w treatment failure • Multivariate adjustment (addressed confounders ie severity of illness) – no association between treatment group and outcome

  29. Osteomyelitis • 10y male admitted for fever, L foot pain • MRI confirmed evidence of osteomyelitis • Patient started on Clinda IV

  30. P: In patients with osteomyelitis does I: Early transition to PO Abx C: Versus prolonged IV therapy O: Affect clinical outcomes?

  31. Prolonged Intravenous Therapy Versus Early Transition to Oral Antimicrobial Therapy for Acute Osteomyelitis in Children TheoklisZaoutis, et al. Pediatrics 2009; 123;636 DOI: 10.15442/peds.2008-0596

  32. Prolonged Intravenous Therapy Versus Early Transition to Oral Antimicrobial Therapy for Acute Osteomyelitis in Children TheoklisZaoutis, et al. Pediatrics 2009; 123;636 DOI: 10.15442/peds.2008-0596

  33. Prolonged IV Therapy Versus Early Transition to PO for Osteomyelitis • Objective: Compare the effectiveness of early transition from IV to PO for acute, uncomplicated osteo • Methods: Retrospective cohort study (PHIS) • Children aged 2m-17y dx with osteo between 2000-2005 at 29 free-standing children’s hospitals • Results: • 1o outcome: Tx failure (readmission w/in 6m) • 2o outcome: Readmit w/in 6m for line complication, adverse drug rxn, C. Diff, agranulocytosis

  34. Prolonged IV Therapy Versus Early Transition to PO for Osteomyelitis Results: 1021 prolonged IV, 948 PO • Overall readmission rate significantly higher in prolonged IV group (10% vs 6%, p= 0.017) • 1o outcome • 5% for prolonged IV group; 4% PO group • No significant association btw Tx failure and mode Abx therapy • 2o outcome • Prolonged IV therapy group more likely to experience Tx-related complication • 3% readmitted for catheter complications, 1.6% for Abx complications (vs 0.4% in PO group, p= 0.005)

  35. GERD • 2m FT male admitted for persistent emesis with feeds associated with back arching, fussiness • Pt growing appropriately • Work-up only reveals reflux

  36. GERD • 2m FT male admitted for persistent emesis with feeds associated with back arching, fussiness • Pt growing appropriately • Work-up only reveals reflux

  37. Are there risks associated with empiric acid suppression treatment of infants and children suspected of having GERD Erica Y. Chung and Jeremy Yardley Hospital Pediatrics 2013;3;16 DOI: 10.1542/hpeds.2012-0077

  38. Are there risks associated with acid suppression therapy? • Objective: Evaluate the potential serious adverse effects associated with acid suppressive meds in the pediatric population • Methods: PubMed search • Ages 0-18y; placebo-controlled or comparisons with a nonacid suppression arm • Results: 14 studies included • NICU, PICU, non-critical care

  39. Are there risks associated with acid suppression therapy? Results • NICU • Increased risk NEC, sepsis/bacteremia • PICU • Mixed results on VAP • Non-critical care • Increased rate PNA, LRTI, gastroenteritis • Associated with C. Diff associated disease

  40. Bronchiolitis • 6wk female admitted with URI symptoms, increased WOB and fever found to be RSV+ • Should she be evaluated for SBI?

  41. P: In infants with bronchiolitis I: Is testing for serious bacterial infection C: Compared to not testing O: Indicated?

  42. Risk of serious bacterial infection in young febrile infants with RSV infections Levine D, et al. Pediatrics 2004; 113;1728-1734 DOI: 10.1542/peds.113.6.1662

  43. Serious Bacterial Infections in Infants with RSV • Methods: Multi-center prospective, cross-sectional study (1998-2001) • All febrile infants, aged 0-60d undergoing SBI eval • RSV testing by antigen detection from NP swabs • Results • 1248 enrolled (22% tested + RSV) • Overall SBI rate 11.4% (0.7% meningitis, 2% bacteremia, 9.1% UTI) • RSV+ infants less likely to have SBI (7% vs 12.5%; RR 0.6)

  44. Table 3. SBI by RSV Status

  45. Serious Bacterial Infections in Infants with RSV Results: Age-stratified • <28d: Overall rate of SBI did not differ significantly btw those who were RSV+ and RSV- (10.1% vs 14.2%, RR 0.71, 95% CI 0.35-1.5) • 29-60d: Overall rate of SBI was 5.5% (no bacteremia or meningitis) with statistically significant difference between RSV+ and RSV- (5.5% vs 11.7%, RR 0.47, 85% CI 0.24-0.91)

  46. HSV • 20d male presenting with fever and irritability • No maternal history of HSV • Full SBI evaluation initiated • Should HSV and empiric Acyclovir be done?

  47. P: In infants presenting for evaluation I/C: What history/PE/labs are associated O: With HSV infection

More Related